Tag: hypervascular tumour

Embrace

First patients enrolled in the Embrace hydrogel embolic system global randomised...

The initial patients have been enrolled in the Embrace hydrogel embolic system (HES) global randomised clinical trial for the treatment of hypervascular tumours, Instylla...

ABK Biomedical appoints Michael J Mangano as president and CEO

ABK Biomedical, a company dedicated to the research, development and commercialisation of innovative embolic therapies, has announced the appointment of Michael J Mangano as...